|
Cavidad oral y faringe. Guías clínicas. |
|
|
|
|
ACR Appropriateness Criteria® local-regional therapy for resectable oropharyngeal squamous cell carcinomas. American College of Radiology . 2010. NGC. Throat (Laryngeal and Pharyngeal) Cancer. National Cancer Institute. 2011 En español. Laringe y faringe. ESMO Guidelines Working Group Nasopharyngeal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Annals of Oncology 20 (Supplement 4): iv123–iv125, 2009 National Comprehensive Cancer Network (NCCN) Head and Neck Cancers NCCN Clinical Practice Guidelines in Oncology . 2010. Hypopharyngeal cancer. Dutch Head and Neck Oncology Cooperative Group. Amsterdam, The Netherlands: Association of Comprehensive Cancer Centres; 2007 Jan . NGC. OncoGuía de orofaringe. AATRML'Agència d'Avaluacio de Tecnologia i Recerca Mèdiques(Cataluña). 2004. Chemotherapy with radiotherapy for nasopharyngeal cancer. Toronto (ON): Cancer Care Ontario (CCO); 2004 Dec. 24 p. (Evidence-based series; no. 5-7). 2004. Screening for Oral Cancer. U.S. Preventive Services Task Force. Agency for Healthcare Research and Quality. 2004. The Role of Chemotherapy with Radiotherapy in the Management of Patients with Newly Diagnosed Locally Advanced Squamous Cell or Undifferentiated Nasopharyngeal Cancer. Cancer Care Ontario. 2004. NGC. DARE.
|
|
Ultima actualización ( Jueves 16 de Junio de 2011 08:15 )
|